Fortrea Holdings (FTRE) Change in Accured Expenses (2022 - 2026)

Fortrea Holdings (FTRE) reported Change in Accured Expenses of -$43.4 million for Q1 2026, down 60.15% on a YoY basis from -$108.9 million in Q1 2025, and down 291.19% quarter-over-quarter from $22.7 million in Q4 2025.

Fortrea Holdings (FTRE) Change in Accured Expenses (2022 - 2026) Analysis & Trends

Fortrea Holdings has reported Change in Accured Expenses for 5 years, with the latest figure at -$43.4 million in Q1 2026.

  • For the quarter ending Q1 2026, Change in Accured Expenses fell 60.15% year-over-year to -$43.4 million; the trailing twelve-month figure through Mar 2026 stood at -$9.8 million (down 351.28% YoY), and the FY2025 full-year result was $6.5 million, up 30.0% from the prior year.
  • Change in Accured Expenses for Q1 2026 stood at -$43.4 million, down from $22.7 million in the prior quarter.
  • The five-year high for Change in Accured Expenses was $80.3 million in Q2 2023, with the low at -$65.1 million in Q1 2023.
  • Historically, Change in Accured Expenses has averaged -$3.5 million across 5 years, with a median of -$20.7 million in 2024.
  • Annual changes were most pronounced in 2024 — Change in Accured Expenses tumbled 96.26% — and 2025, when it surged 746.67%.
  • Fortrea Holdings' Change in Accured Expenses stood at -$22.7 million in 2022, then soared by 253.3% to $34.8 million in 2023, then surged by 39.94% to $48.7 million in 2024, then plunged by 53.39% to $22.7 million in 2025, then plunged by 291.19% to -$43.4 million in 2026.
  • The last three Change in Accured Expenses figures came in at -$43.4 million (Q1 2026), $22.7 million (Q4 2025), and -$14.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 931,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 644,700.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 70.50 Mn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Fortrea Holdings 1.43 Bn 1.28 Bn 123.60 Mn -43.40 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -43.40 Mn
Mar 31, 2026 -43.40 Mn
Dec 31, 2025 22.70 Mn
Dec 31, 2025 22.70 Mn
Sep 30, 2025 -14.50 Mn
Sep 30, 2025 -14.50 Mn
Jun 30, 2025 25.40 Mn
Jun 30, 2025 25.40 Mn
Mar 31, 2025 -27.10 Mn
Mar 31, 2025 -27.10 Mn
Dec 31, 2024 48.70 Mn
Dec 31, 2024 48.70 Mn
Sep 30, 2024 -20.70 Mn
Sep 30, 2024 -20.70 Mn
Jun 30, 2024 3.00 Mn
Jun 30, 2024 3.00 Mn
Mar 31, 2024 -26.00 Mn
Mar 31, 2024 -26.00 Mn
Dec 31, 2023 34.80 Mn
Dec 31, 2023 34.80 Mn